What's new
Human medicines European public assessment report (EPAR): Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron), dinutuximab beta, Neuroblastoma, Date of authorisation: 08/05/2017, Revision: 14, Status: Authorised
31 March 2023
European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties joint meeting, Hybrid, from 03/03/2023 to 03/03/2023
31 March 2023
Human medicines European public assessment report (EPAR): Aldurazyme, laronidase, Mucopolysaccharidosis I, Date of authorisation: 09/06/2003, Revision: 24, Status: Authorised
31 March 2023
Herbal medicinal product: Fragariae folium, Fragariae folium, C: ongoing call for scientific data
31 March 2023
Call for scientific data for the periodic review of the monograph on Fragariae folium - Revision 1
31 March 2023
Guideline on Quality Aspects of Pharmaceutical Veterinary Medicines for administration via drinking water - Draft Annex on compatibility studies between veterinary medicinal products and biocidal products
31 March 2023